Clinical Trial Update: Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety of ToleroMune Ragweed in ragweed-allergic individuals with rhinoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis
• Ragweed Allergy

Drugs mentioned

• ToleroMune Ragweed (ToleroMune Ragweed)

Snippet

Sponsor: Circassia Limited | Conditions: Allergy | Phase 2 | Status: COMPLETED